Donation
Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19
Mylan
PR-M08-20-NI-22Aug 14, 2020
COVID-19 Treatment
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
Mylan
PR-M05-20-NI-018May 14, 2020
Leadership
Mylan Board Appoints Robert J. Coury As Executive Chairman
Mylan
PR-M04-20-NI-026Apr 17, 2020
M&A
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mylan
PR-M03-20-NI-041Mar 26, 2020
Legal Settlement
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Mylan
PR-M09-19-NI-060Sep 30, 2019
Legal
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Nice Insight
PR-M08-19-NI-007Aug 02, 2019
M&A
Mylan and Upjohn, a Division Of Pfizer, to Combine
Pfizer
PR-M07-19-NI-079Jul 31, 2019
Recall
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter
Mylan
PR-M03-19-NI-050Mar 19, 2019
Opioids
Generic Suboxone Sublingual Film Launched
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-004Mar 05, 2019
FDA Approval
Mylan Announces FDA Approval of Wixela™ Inhub™, First Generic of ADVAIR DISKUS®
Mylan
PR-M02-19-NI-005Feb 05, 2019
Launch
Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering
Mylan
PR-M01-19-NI-001Jan 02, 2019
Gastroenterology
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets
Mylan
PR-M12-18-NI-022Dec 07, 2018
FDA Inspection
Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant
Mylan
PR-M11-18-NI-093Nov 27, 2018
Biosimilars
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Mylan
PR-M10-18-NI-071Oct 22, 2018
Clinical Data
Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting
Mylan
PR-M10-18-NI-038Oct 11, 2018
Generics
Mylan Launches Authorized Generic of Ampyra® Tablets
Mylan
PR-M09-18-NI-089Sep 27, 2018
Biosimilar
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Mylan
PR-M09-18-NI-087Sep 27, 2018
Generics
Mylan Launches First Generic for Adcirca® Tablets
Mylan
PR-M09-18-NI-021Sep 10, 2018
Biosimilar
Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio™, Biosimilar Adalimumab
Mylan
PR-M08-18-NI-001Aug 01, 2018
Drug Development
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch
Mylan
PR-M07-18-NI-028Jul 10, 2018